Causes of death among patients with hepatocellular carcinoma in United States from 2000 to 2018
Cancer Medicine · 2023-06 · 12 (12) · 13076-13085
DOI: 10.1002/cam4.5986 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 21.04.2023. Verfasst von Zhen Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatopancreatobiliary Surgery, Qingdao Municipal Hospital, Qingdao University, Qingdao, People's Republic of China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Communicable Diseases, Cardiovascular Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Background
The gains in survival outcomes of US patients with hepatocellular carcinoma (HCC) have come at the expense of developing non‐cancer‐related morbidities, such as cardiovascular diseases (CVDs) and infections. However, population‐based data on causes of death (CODs) in patients with HCC are scarce.
Methods
A cancer registry database in the United States was used to analyze the CODs among patients with HCC. Death cause distribution and standardized mortality ratios were calculated to quantify the disease‐specific death burden.
Results
A total of 40,094 patients with a histological diagnosis of HCC were identified from the SEER‐18 database between 2000 and 2018, of which 30,796 (76.8%) died during the follow‐up period. The majority of these deaths (25,153, 81.7%) occurred within 2 years after diagnosis, 13.2% (4075) occurred within 2–5 years, and 5.1% (1568) occurred after 5 years. All age groups had a lower burden of female deaths than of male deaths during the study period. With respect to CODs, 23,824 (77.4%), 2289 (7.4%), and 4683 (15.2%) were due to HCC, other cancers, and non‐cancer causes, respectively. Non‐cancer‐related deaths were more common among older patients and those with longer latency periods since diagnosis. The major causes of non‐cancer‐related deaths are other infectious and parasitic diseases, including HIV and CVDs.
Conclusions
CODs during HCC survivorship varied, and a growing number of survivors tended to die from causes other than HCC, with an increasing latency period since diagnosis. Comprehensive analyses of mortality patterns and temporal trends could underpin strategies to reduce these risks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatopancreatobiliary Surgery, Qingdao Municipal Hospital, Qingdao University, Qingdao, People's Republic of China.
- Department of Hepatopancreatobiliary Surgery, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, People's Republic of China.
ORCID-Profile: Zhen Yang, Guangjun Shi
Förderung
- Natural Science Foundation of Shandong Province
Zitieren
APA
Yang, Z., Leng, K., & Shi, G. (2023). Causes of death among patients with hepatocellular carcinoma in United States from 2000 to 2018. Cancer Medicine, 12(12), 13076-13085. https://doi.org/10.1002/cam4.5986
Vancouver
Yang Z, Leng K, Shi G. Causes of death among patients with hepatocellular carcinoma in United States from 2000 to 2018. Cancer Medicine. 2023;12(12):13076-13085. doi:10.1002/cam4.5986
BibTeX
@article{Yang2023,
author = {Yang, Zhen and Leng, Kaiming and Shi, Guangjun},
title = {Causes of death among patients with hepatocellular carcinoma in United States from 2000 to 2018},
journal = {Cancer Medicine},
year = {2023},
volume = {12},
number = {12},
pages = {13076--13085},
doi = {10.1002/cam4.5986}
}
EUVIMED